Acupuncture for Symptoms of Nerve Damage

Completed · Not applicable · Has a placebo group

Conditions studied: Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy

In brief

The purpose of this study is to compare the effects of real acupuncture with placebo acupuncture or usual care on symptoms of nerve damage from chemotherapy.

Key facts

Study ID

NCT03183037

Run by

Memorial Sloan Kettering Cancer Center

People needed

75

Starts

2017-06-07

Expected to finish

2024-05-02

Last updated by the study team

2024-05-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• English-speaking
• Age ≥ 18 years old
• Solid tumor survivors with no evidence of disease
• Moderate to severe CIPN, defined by symptoms such as numbness, tingling, or pain ratings of 4 or greater on a 0-10 numeric rating scale (NRS)
• Have completed neurotoxic chemotherapy at least 3 months prior to enrollment
• If taking anti-neuropathy medications, they are on a stable regimen (no change in 3 months)

You may not qualify if…

• Patients with a pacemaker
• Prior acupuncture treatment within 5 years of enrollment

Where it is running

• Memorial Sloan Kettering Cancer Center @ Commack — Commack, New York, United States
• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.